DUBLIN, July 13, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/mlcdfr/neurotech_insights) has announced the addition of NeuroInsights's new newsletter "Neurotech Insights" to their offering.
Covering Drugs, Devices, and Diagnostics for the Brain and Nervous System
On the first day of each month, Neurotech Insights is delivered to your inbox giving you competitive intelligence on the neurotechnology industry.
Every monthly issue contains:
- Neurotech market activity analysis
- Clinical trials and product news alerts
- Recent deals, alliances, and financings
- Stock tracking and performance data
- Featured company profile
- Editorial articles on hot topics
Each issue includes an in-depth topic review. Recent issues focused on sleep disorders, depression, multiple sclerosis, Parkinson's disease, addiction, epilepsy, anxiety, stem cells, Huntington's, age-associated memory impairment, neurosurgery, spinal cord injury, obsessive compulsive disorder, ALS, neuroplasticity, neuropathic pain, and traumatic brain injury.
Subscribers also have access to a searchable web archive of over 4,000 stories covering more than 800 companies, 300 investors and 80 different brain and nervous system disorders.
For more information visit http://www.researchandmarkets.com/research/mlcdfr/neurotech_insights
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets